Invest Now
Samco Star Rating Ads

SMS Pharmaceuticals Ltd Price Performance

  • Day's Low
  • ₹256.85
  • Day's High
  • ₹263.9
₹ 257.7
  • 52-w low
  • ₹113.3
  • 52-w high
  • ₹398
257.7
  • Day's open
    ₹258
  • Previous close
    ₹256.950012
  • VWAP
    ₹258.68
  • Lower price band
    ₹206.2
  • Upper price band
    ₹309.2

Today's Market Action

The last traded share price of SMS Pharmaceuticals Ltd was 257.70 up by 0.29% on the NSE. Its last traded stock price on BSE was 258.25 up by 0.51%. The total volume of shares on NSE and BSE combined was 165,204 shares. Its total combined turnover was Rs 4.27 crores.

SMS Pharmaceuticals Ltd Medium and Long Term Market Action

SMS Pharmaceuticals Ltd hit a 52-week high of 398 on 23-09-2024 and a 52-week low of 113.3 on 21-12-2023. The stock price of SMS Pharmaceuticals Ltd is down by -12% over the last one month. It is up by 117.56% over the last one year. Don't forget to check the full stock price history in the table below.

SMS Pharmaceuticals Ltd Fundamentals

  • Market Cap (Cr): 2228

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

SMS Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

SMS Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About SMS Pharmaceuticals Ltd

Data not available.

SMS Pharmaceuticals Ltd FAQ's

What is Share Price of SMS Pharmaceuticals Ltd?

What is the Market Cap of SMS Pharmaceuticals Ltd?

What is PE Ratio of SMS Pharmaceuticals Ltd?

What is PB Ratio of SMS Pharmaceuticals Ltd?

What is the CAGR of SMS Pharmaceuticals Ltd?

How to Buy SMS Pharmaceuticals Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 4.88 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.18. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 320 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 19% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(10/12/2024)
Stock Valuation
Green line
100
0.00%
0.00% People are bullish about SMS Pharmaceuticals Ltd
100.00%
100.00 % People are bearish about SMS Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

SMS Pharmaceuticals Ltd

257.70 +0.75 (0.29%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91